Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dr Reddys Laboratories (RDY) Gross Profit (2016 - 2025)

Historic Gross Profit for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to $525.6 million.

  • Dr Reddys Laboratories' Gross Profit fell 953.08% to $525.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.2 billion, marking a year-over-year increase of 301.29%. This contributed to the annual value of $2.2 billion for FY2025, which is 1360.16% up from last year.
  • Dr Reddys Laboratories' Gross Profit amounted to $525.6 million in Q4 2025, which was down 953.08% from $545.8 million recorded in Q1 2025.
  • Dr Reddys Laboratories' Gross Profit's 5-year high stood at $581.0 million during Q4 2024, with a 5-year trough of $467.18 in Q3 2022.
  • Moreover, its 5-year median value for Gross Profit was $476.0 million (2023), whereas its average is $434.7 million.
  • Per our database at Business Quant, Dr Reddys Laboratories' Gross Profit tumbled by 9999.99% in 2022 and then soared by 10452723464.29% in 2023.
  • Over the past 5 years, Dr Reddys Laboratories' Gross Profit (Quarter) stood at $364.0 million in 2021, then grew by 20.6% to $439.0 million in 2022, then increased by 15.46% to $506.9 million in 2023, then grew by 14.62% to $581.0 million in 2024, then decreased by 9.53% to $525.6 million in 2025.
  • Its last three reported values are $525.6 million in Q4 2025, $545.8 million for Q1 2025, and $581.0 million during Q4 2024.